ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

ClinicalTrials.gov ID: NCT05667662

Public ClinicalTrials.gov record NCT05667662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 3:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study to Evaluate the Effect of Dose and Duration of Treatment of Itraconazole Administered as a Dry Powder for Inhalation (PUR1900) on Safety, Tolerability, and Potential Outcomes in Adult Patients With ABPA

Study identification

NCT ID
NCT05667662
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pulmatrix Inc.
Industry
Enrollment
8 participants

Conditions and interventions

Conditions

Interventions

  • Itraconazole Powder Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2023
Primary completion
Feb 26, 2024
Completion
Feb 26, 2024
Last update posted
Apr 1, 2024

2023 – 2024

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
University of Alabama Medical Center at Birmingham Birmingham Alabama 35233
Medical Research of Arizona Scottsdale Arizona 85251
Jonathan Corren, MD Santa Monica California 90025
Bensch Clinical Research Stockton California 95207
Southern Illinois University Center for Clinical Research Springfield Illinois 62702
University of Kansas Medical Center Research Institute Kansas City Kansas 66160
Baylor University Medical Center Dallas Texas 75246
UTMB Health Galveston Texas 77555

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05667662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2024 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05667662 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →